Wednesday, February 10, 2010, 9:50AM AEST - The Australian Stockmarket opens in 10 minutes.
To create a watchlist or portfolio of shares, Register

Champions Biotechnology, Inc. (CSBR.OB)

On Feb 9: 0.75 USD   0.00 (0.00%)  
 MORE ON CSBR.OB 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 CHAMPIONS BIOTECHNLG (OTC BB:CSBR.OB) Delayed quote dataEdit
Last Trade:0.75 USD
Trade Time:Feb 9
Change: 0.00 (0.00%)
Prev Close:0.75
Open:N/A
Bid:0.75 x 2500
Ask:0.80 x 2500
1y Target Est:N/A
Day's Range:N/A - N/A
52wk Range:0.55 - 1.24
Volume:0
Avg Vol (3m):3,811.29
Market Cap:24.65M
P/E (ttm):N/A
EPS (ttm):-0.11
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add CSBR.OB to Portfolio   Download Data

 HEADLINES 
CHAMPIONS BIOTECHNOLOGY, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Fri, Dec 25)
CHAMPIONS BIOTECHNOLOGY, INC. Financials
EDGAR Online Financials (Sun, Dec 20)
CHAMPIONS BIOTECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Thu, Dec 17)
Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
PR Newswire (Wed, Dec 16)
CHAMPIONS BIOTECHNOLOGY, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Dec 16)
Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
PR Newswire (Thu, Nov 19)
Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
PR Newswire (Fri, Nov 13)
CHAMPIONS BIOTECHNOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Thu, Oct 8)
CHAMPIONS BIOTECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Fri, Sep 18)
CHAMPIONS BIOTECHNOLOGY, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Sep 15)
More Headlines for CSBR.OB...

 BUSINESS SUMMARY 
Champions Biotechnology, Inc., a biotechnology company, engages in the development of advanced preclinical platforms and predictive tumor specific data to enhance the value of oncology drugs in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices